Top Markets
Coin of the day
Elbit Medical Technologies Ltd Elbit Medical Technologies Ltd

Elbit Medical Technologies Ltd

EMTC-M
Rang in aandelen #40900
Elbit Medical Technologies Ltd functions as an investment holding company, with... Elbit Medical Technologies Ltd functions as an investment holding company, with its core activities centered on the innovation, production, and global commercialization of therapeutic medical devices. The company maintains a presence across the United States, Europe, and other international territories. A key initiative involves the advancement of a magnetic resonance imaging (MRI) guided focused ultrasound treatment system, designed to tackle a range of medical challenges, including various cancers (oncology), gynecological conditions, neurological disorders, and tumors. Additionally, Elbit Medical Technologies is engaged in the extensive study and creation of medical products leveraging stem cells, predominantly sourced from umbilical cord blood. These stem cell applications are critical for bone marrow transplants in individuals affected by leukemia, lymphatic system cancers, non-malignant hematological diseases, and inherited metabolic genetic conditions. Headquartered in Petah Tikva, Israel, Elbit Medical Technologies Ltd is a wholly-owned subsidiary of Exigent Management Ltd.
Aandeelprijs
$0.07188945
Laatst gesynchroniseerd: 2026-02-17
Marktkapitalisatie
$65.22K
Verandering (1 dag)
-7.50%
Verandering (1 jaar)
10.44%
Land
IL
Handel Elbit Medical Technologies Ltd (EMTC-M)

Categorie

Aandelsplitsingen voor Elbit Medical Technologies Ltd (EMTC-M)
Het aandeel Elbit Medical Technologies Ltd (symbool: EMTC-M) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 13, 2026.
Eén aandeel EMTC-M dat vóór Aug 13, 2026 werd gekocht, staat nu gelijk aan 0 aandelen EMTC-M.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
3 x12
US